Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

I think it was even harder for him, being on active duty — the shame and the stigma. He wanted to get more help,” an ...

Studies show psilocybin from mushrooms could revolutionize depression treatment offering hope to millions who don't respond to traditional medications.

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

According to a new study, ketamine use has risen significantly since 2015. The results highlight the need for closer monitoring of recreational ketamine use.

Scientists have discovered how brain circuits affected by stress can predict resilience in mice. By stimulating certain ...

Participants in clinic trial went from being unable to get out of bed to being productive and interacting with loved ones ...

The legalization of “magic” mushrooms comes as people increasingly turn to psychedelics to treat anxiety, depression and ...

In a groundbreaking Interview, Professor Raz Yirmiya discusses his innovative research at the intersection of inflammation ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

People explore different treatments and therapies to help with depression, and recently, researchers wanted to understand if ...

A groundbreaking depression treatment co-pioneered by Queensland researchers using a new form of brain stimulation will begin ...